Učitavanje...
Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital
BACKGROUND: Living donor liver transplantation (LDLT) is an established treatment not only for those with end-stage liver disease but for those with hepatocellular carcinoma (HCC) developing in cirrhotic liver. The aim of this study was to present a single-center experience of LDLT for HCC at the Un...
Spremljeno u:
| Izdano u: | Hepatobiliary Surg Nutr |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5075828/ https://ncbi.nlm.nih.gov/pubmed/27826554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2016.08.05 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|